Brind.

Incepta Pharmaceuticals and Amphastar Pharmaceuticals were ranked in the Generic Drugs industry.

1 report, 1 independent Updated Sep 2
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Incepta Pharmaceuticals and Amphastar Pharmaceuticals were ranked in the Generic Drugs industry.

Who's involved

What this event is mainly about
Incepta PharmaceuticalsAmphastar Pharmaceuticals

How it developed

Newest first. Tap a step to see who reported it.
  1. Amphastar Pharmaceuticals reported its Q2 financial results on August 6, 2025.Sub-event
  2. FDA approved a generic drug, leading to a market rally, involving Amphastar Pharmaceuticals.Sub-event
  3. Ranked in the Generic Drugs industry.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • ZacksIs the Options Market Predicting a Spike in Amphastar Pharmaceuticals Stock? Investors in Amphastar Pharmaceuticals, Inc. AMPH need to pay close attention to the stock based on moves in the options m